~~<i id='68BA4E6E36'><strike id='68BA4E6E36'><tt id='68BA4E6E36'><pre id='68BA4E6E36'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：leisure time 2025-09-27 12:43:14 - browse：573

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： UnitedHealth argues against case alleging wrongful AI care denials

leisure time

focus

explore

Wikipedia

hotspot

AdobeWhatisthebestwaytofixfaultybloodcells,anddosoforthemostpeople?That’sthequestionahordeofgeneedit

WSS

Addressing health care workers' trauma can help fight burnout

Eyeing GLP

Scrutiny of post

Mitch McConnell episode has important public health takeaway

National panel will explore requiring free Covid tests

Citing H5N1 threat, CDC urges peak flu monitoring this summer

hotspot

explore

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Investigation reveals sickle cell patients pressured into sterilizations

Malaria cases in Florida and Texas: Here’s what you need to know

Cue Health, Covid

Medicare details structure of new drug price negotiation program

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Cancer drug shortages should be causing more outrage

Addressing health care workers' trauma can help fight burnout

At least 13 dead in Texas as scorching temps continue

National panel will explore requiring free Covid tests

focus

No plane should take off without an EpiPen onboard

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Investigation reveals sickle cell patients pressured into sterilizations

FDA poised to publish guidelines for clinical trial diversity

Study finds gene variants tied to breast cancer risk in Black women

New safety details link Apellis eye drug to rare cases of blindness

focus

explore

Wikipedia

hotspot